HomeCompareHUGE vs QYLD

HUGE vs QYLD: Dividend Comparison 2026

HUGE yields 2224.69% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HUGE wins by $26886357809.28M in total portfolio value
10 years
HUGE
HUGE
● Live price
2224.69%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26886357809.31M
Annual income
$24,702,111,776,993,104.00
Full HUGE calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — HUGE vs QYLD

📍 HUGE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHUGEQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HUGE + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HUGE pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HUGE
Annual income on $10K today (after 15% tax)
$189,099.00/yr
After 10yr DRIP, annual income (after tax)
$20,996,795,010,444,136.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, HUGE beats the other by $20,996,795,010,439,324.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HUGE + QYLD for your $10,000?

HUGE: 50%QYLD: 50%
100% QYLD50/50100% HUGE
Portfolio after 10yr
$13443178904.67M
Annual income
$12,351,055,888,499,382.00/yr
Blended yield
91.88%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HUGE buys
0
QYLD buys
1
PoliticianChamberTickerTypeAmountDate
Tim Moore🏢 House$QYLD▼ Sell$15,001 - $50,0002025-05-02
Tim Moore🏢 House$QYLD▲ Buy$15,001 - $50,0002025-04-07
Dwight Evans🏢 House$QYLD▼ Sell$1,001 - $15,0002022-11-14
Dwight Evans🏢 House$QYLD▼ Sell$1,001 - $15,0002020-10-29
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHUGEQYLD
Forward yield2224.69%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$26886357809.31M$25.4K
Annual income after 10y$24,702,111,776,993,104.00$5,659.31
Total dividends collected$26732540812.68M$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: HUGE vs QYLD ($10,000, DRIP)

YearHUGE PortfolioHUGE Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$233,169$222,469.41$10,352$1,192.36+$222.8KHUGE
2$5,097,441$4,847,949.65$10,830$1,347.57+$5.09MHUGE
3$104,504,369$99,050,107.14$11,460$1,539.07+$104.49MHUGE
4$2,009,632,678$1,897,813,002.91$12,275$1,777.84+$2009.62MHUGE
5$36,257,963,200$34,107,656,235.06$13,323$2,078.95+$36257.95MHUGE
6$613,911,185,428$575,115,164,804.17$14,667$2,463.34+$613911.17MHUGE
7$9,757,551,142,472$9,100,666,174,063.52$16,396$2,960.57+$9757551.13MHUGE
8$145,624,394,080,622$135,183,814,358,176.64$18,631$3,612.97+$145624394.06MHUGE
9$2,041,351,432,070,910$1,885,533,330,404,645.00$21,548$4,482.15+$2041351432.05MHUGE
10$26,886,357,809,308,976$24,702,111,776,993,104.00$25,398$5,659.31+$26886357809.28MHUGE

HUGE vs QYLD: Complete Analysis 2026

HUGEStock

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.

Full HUGE Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this HUGE vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HUGE vs SCHDHUGE vs JEPIHUGE vs OHUGE vs KOHUGE vs MAINHUGE vs XYLDHUGE vs JEPQHUGE vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.